GGrantIndex
Sort

23,748 grants matching melanoma

Characterization of the Pathogenesis of Lymphangioleiomyomatosis (LAM)

$2,941,694
Joel Moss · National Heart, Lung, And Blood Institute · ZIA · FY2024 · HL

Hyperthermia and Perfusion Effects in Cancer Therapy

$2,938,079
Duke University · P01 · FY2005 · CA

LICI Microbiome and Genetics Core

$2,935,451
Colm Ohuigin · Division Of Basic Sciences - Nci · ZIC · FY2025 · CA

Targeting the Chemokine System to Sensitize Tumors to Immunotherapy

$2,934,547
Pawel Kalinski · Roswell Park Cancer Institute Corp · P01 · FY2021 · CA

Gene therapy of cancer

$2,934,429
Steven Rosenberg · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA

Adoptive Cell Transfer Immunotherapy of Cancer

$2,934,429
Steven Rosenberg · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA

CHEMOPREVENTION OF SKIN CANCER PROGRAM PROJECT

$2,933,653
University Of Arizona · P01 · FY2002 · CA

Moffitt Cancer Center Support Grant

$2,930,104
Thomas A Sellers · H. Lee Moffitt Cancer Ctr & Res Inst · P30 · FY2015 · CA

Moffitt Cancer Center Support Grant

$2,930,104
Thomas A Sellers · H. Lee Moffitt Cancer Ctr & Res Inst · P30 · FY2016 · CA

Studies of Occupational Cancer (Pesticides)

$2,929,796
Michael Alavanja · Division Of Cancer Epidemiology And Genetics · ZIA · FY2013 · CA

Studies of Populations Exposed to Environmental Sources of Radiation

$2,915,621
Elizabeth Cahoon · Division Of Cancer Epidemiology And Genetics · ZIA · FY2024 · CA

Stem Cell-Engineered Tumor Immunity in Man

$2,904,341
David Baltimore · California Institute Of Technology · P01 · FY2011 · CA

Stem Cell-Engineered Tumor Immunity in Man

$2,898,964
David Baltimore · California Institute Of Technology · P01 · FY2012 · CA

Studies of Occupational Cancer (Pesticides)

$2,897,023
Michael Alavanja · Division Of Cancer Epidemiology And Genetics · ZIA · FY2010 · CA

DNA Sequencing and FACS Core Facilities

$2,894,589
Paul Robbins · Division Of Basic Sciences - Nci · ZIC · FY2023 · CA

Moffitt Cancer Center Support Grant

$2,891,925
John L. Cleveland · H. Lee Moffitt Cancer Ctr & Res Inst · P30 · FY2019 · CA

OHSU Knight Cancer Institute

$2,891,535
Brian J Druker · Oregon Health & Science University · P30 · FY2022 · CA

OHSU Knight Cancer Institute

$2,891,535
Lisa M Coussens · Oregon Health & Science University · P30 · FY2024 · CA

OHSU Knight Cancer Institute

$2,891,535
Thomas A Sellers · Oregon Health & Science University · P30 · FY2023 · CA

OHSU Knight Cancer Institute

$2,891,535
Shivaani Kummar · Oregon Health & Science University · P30 · FY2025 · CA

Rational approaches to melanoma therapy

$2,885,586
Meenhard Herlyn · Wistar Institute · U54 · FY2017 · CA

Hyperthermia and Perfusion Effects in Cancer Therapy

$2,885,560
Mark Wesley Dewhirst · Duke University · P01 · FY2006 · CA

SPORE in Skin Cancer

$2,885,390
Brigham And Women'S Hospital · P50 · FY2003 · CA

Hyperthermia and Perfusion Effects in Cancer Therapy

$2,876,950
Mark Wesley Dewhirst · Duke University · P01 · FY2007 · CA

Targeting the Chemokine System to Sensitize Tumors to Immunotherapy

$2,875,855
Pawel Kalinski · Roswell Park Cancer Institute Corp · P01 · FY2023 · CA